Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis

Clinical Therapeutics

Volumn 26, Issue 11, 2004, Pages 1890-1894

  Anlar, Banu ^a   Aydin, Omer Faruk ^b   Guven, Alev ^c   Sonmez, Fatma Mujgan ^d   Kose, Gulsen ^c   Herguner, Ozlem ^e  

^a HACETTEPE UNIVERSITY   (Turkey)

^b DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^c Social Security Hospital   (Turkey)

^d KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^e CUKUROVA UNIVERSITY   (Turkey)

Author keywords

subacute sclerosing panencephalitis interferon treatment

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; METHISOPRINOL;

ARTICLE; CALCULATION; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FEVER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MENTAL FUNCTION; MENTAL HEALTH; MOTOR PERFORMANCE; PARAMETER; PATIENT; RETROSPECTIVE STUDY; SENSORY ANALYSIS; SENSORY SYSTEM; SUBACUTE SCLEROSING PANENCEPHALITIS; SURVIVAL TIME; TIME; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; INOSINE PRANOBEX; INTERFERON-BETA; MALE; RETROSPECTIVE STUDIES; SUBACUTE SCLEROSING PANENCEPHALITIS; SURVIVAL ANALYSIS;

EID: 11844266613     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2004.11.002     Document Type: Article

References (14)

1. Risk W.S., and Haddad F.S. The variable natural history of subacute sclerosing panencephalitis: A study of 118 cases from the Middle East Arch Neurol. 36 1979 610 614
2. Anlar B., Yalaz K., Kose G., and Saygi S. Beta-interferon plus mosiplex in the treatment of subacute sclerosing panencephalitis J Child Neurol. 13 1998 557 559
3. Chabot S., and Yong V.W. Interferon beta-lb increases interleukin-10 in a model of T cell-microglia interaction: Relevance to MS Neurology 55 2000 1497 1505
4. Floris S., Ruuls S.R., and Wierinckx A. Interferon-beta directly influences monocyte infiltration into the central nervous system J Neuroimmunol. 127 2002 69 79
5. Anlar B., Soylemezoglu F., and Aysun S. Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE) J Child Neurol. 16 2001 895 900
6. Yalaz K., Anlar B., and Oktem F. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis Neurology. 42 1992 488 491
7. Dyken P.R., Swift A., and DuRant R.H. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with mosiplex Ann Neurol. 11 1982 359 364
8. Öktem F., Nester M.J., and Anlar B. Mental assessment in subacute sclerosing panencephalitis: Hacettepe Cognitive Short Assessment Scale J Child Neurol. 12 1997 398 402
9. Gascon G.G., and International Consortium on Sub acute Sclerosing Panencephalitis Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): International multicenter study J Child Neurol. 18 2003 819 827
10. Aydin O.F., Senbil N., Kuyucu N., and Gurer Y.K. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis J Child Neurol. 18 2003 104 108
11. Anlar B. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan Brain Dev. 26 2004 345
12. Anlar B. Preliminary results for treatments in subacute sclerosing panencephalitis have problems? J Child Neurol. 19 2004 463
13. Anlar B., Yalaz K., Oktem F., and Ease G. Long-term followup of subacute sclerosing panencephalitis patients treated with intraventricular alpha-interferon Neurology 48 1997 526 528
14. Coyle P.K., and Hartung H.P. Use of interferon beta in multiple sclerosis: Rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response Mutt Scler 8 2002 2 9